β¨ Medicine Distribution Consents
29 SEPTEMBER 2005 NEW ZEALAND GAZETTE, No. 165
4137
Product: Nupentin
Active Ingredient: Gabapentin 300mg
Dosage Form: Capsule
New Zealand Sponsor: Pacific Pharmaceuticals Limited
Manufacturer: Alphapharm Pty Limited, Carole Park, Brisbane, Queensland, Australia
Product: Nupentin
Active Ingredient: Gabapentin 400mg
Dosage Form: Capsule
New Zealand Sponsor: Pacific Pharmaceuticals Limited
Manufacturer: Alphapharm Pty Limited, Carole Park, Brisbane, Queensland, Australia
Product: Paclitaxel Ebewe
Active Ingredient: Paclitaxel 6mg/mL
Dosage Form: Concentrate for injection
New Zealand Sponsor: InterPharma Pty Limited
Manufacturer: Ebewe Pharma GmbH Nfg KG, Unterach am Attersee, Austria
Dated this 11th day of September 2005.
DON MATHESON, Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health on 6 July 2001).
go6306
Consent to the Distribution of a Changed Medicine
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the changed medicine which was referred to the Minister of Health under the provisions of section 24 (5) of the Act and is set out in the Schedule hereto:
Schedule
Product: Fabrazyme
Active Ingredient: Agalsidase beta - rch 35mg
Dosage Form: Powder for infusion
New Zealand Sponsor: Medra Services Limited
Manufacturer: Genzyme Corporation, Allston, Massachusetts, United States of America
Dated this 11th day of September 2005.
DON MATHESON, Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health on 6 July 2001).
go6305
Consent to the Distribution of New Related Products
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new related products set out in the Schedule hereto:
Schedule
Product: Colgate Max Fresh Whitening - Clean Mint
Active Ingredient: Sodium fluoride 0.22%w/w equivalent to fluoride ion 1000ppm
Dosage Form: Toothpaste
New Zealand Sponsor: Colgate-Palmolive Limited
Manufacturer: Colgate-Palmolive Pty Limited, Labrador, Queensland, Australia
Product: Colgate Max Fresh Whitening - Cool Mint
Active Ingredient: Sodium fluoride 0.22%w/w equivalent to fluoride ion 1000ppm
Dosage Form: Toothpaste
New Zealand Sponsor: Colgate-Palmolive Limited
Manufacturer: Colgate-Palmolive Pty Limited, Labrador, Queensland, Australia
Product: Colgate Max Fresh Whitening 2 in 1 - Clean Mint
Active Ingredient: Sodium fluoride 0.22%w/w equivalent to fluoride ion 1000ppm
Dosage Form: Toothpaste
New Zealand Sponsor: Colgate-Palmolive Limited
Manufacturer: Colgate-Palmolive Pty Limited, Labrador, Queensland, Australia
Product: Colgate Max Fresh Whitening 2 in 1 - Cool Mint
Active Ingredient: Sodium fluoride 0.22%w/w equivalent to fluoride ion 1000ppm
Dosage Form: Toothpaste
New Zealand Sponsor: Colgate-Palmolive Limited
Manufacturer: Colgate-Palmolive Pty Limited, Labrador, Queensland, Australia
Dated this 26th day of September 2005.
DON MATHESON, Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health on 6 July 2001).
go6474
Next Page →
Online Sources for this page:
VUW Te Waharoa —
NZ Gazette 2005, No 165
Gazette.govt.nz —
NZ Gazette 2005, No 165
β¨ LLM interpretation of page content
π₯
Consent to Distribution of New Medicines
(continued from previous page)
π₯ Health & Social Welfare11 September 2005
Medicines, Distribution, Nupentin, Gabapentin, Paclitaxel
- DON MATHESON, Deputy Director-General, Public Health
π₯ Consent to the Distribution of a Changed Medicine
π₯ Health & Social Welfare11 September 2005
Medicines, Distribution, Fabrazyme, Agalsidase beta
- DON MATHESON, Deputy Director-General, Public Health
π₯ Consent to the Distribution of New Related Products
π₯ Health & Social Welfare26 September 2005
Medicines, Distribution, Toothpaste, Colgate Max Fresh
- DON MATHESON, Deputy Director-General, Public Health